|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/69 | |
| C07F 5/04 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3471734 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17739381.6 |
| Europos patento paraiškos padavimo data | 2017-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/036482 |
| Data | 2017-06-08 |
| (87) | Numeris | WO 2017/222819 |
| Data | 2017-12-28 |
| (30) | Numeris | Data | Šalis |
| 201662352787 P | 2016-06-21 | US | |
| 201662438073 P | 2016-12-22 | US |
| (72) |
VALIK, Martin, CZ
GABRIEL, Roman, CZ
VRASPIR, Pavel, CZ
LUKAS, David, CZ
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | SOLID STATE FORMS OF IXAZOMIB CITRATE |
| SOLID STATE FORMS OF IXAZOMIB CITRATE |